ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,408Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 1206

$656K Total Retail Price of All Prescriptions

Rank: 61 out of 1206

651 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 651 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 651 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,160 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 634 582 1 1
AMLODIPINE BESYLATE 532 508 2 6
BENAZEPRIL HCL 402 363 3 39
FUROSEMIDE 389 354 4 5
LEVOTHYROXINE SODIUM 353 306 5 2
HYDROCODONE-ACETAMINOPHEN 313 287 S3 6 7
METOPROLOL TARTRATE 290 274 7 9
WARFARIN SODIUM 281 262 8 8
OMEPRAZOLE 265 237 9 3
METFORMIN HCL 257 216 10 10
ATORVASTATIN CALCIUM 209 183 11 13
GLIMEPIRIDE 209 177 11 34
PRAVASTATIN SODIUM 195 184 13 21
ATENOLOL 180 167 14 14
POTASSIUM CHLORIDE 169 165 15 12
LOSARTAN POTASSIUM 168 155 16 20
CRESTOR 164 149 17 30
HYDROCHLOROTHIAZIDE 160 149 18 11
TAMSULOSIN HCL 154 154 19 26
CARVEDILOL 146 138 20 32
LISINOPRIL 145 144 21 4
TRAMADOL HCL 138 103 22 17
GABAPENTIN 137 96 23 18
AMLODIPINE BESYLATE-BENAZEPRIL 136 118 24 76
METOPROLOL SUCCINATE 135 133 25 15
CITALOPRAM HBR 130 108 26 16
ALENDRONATE SODIUM 128 123 27 19
FENOFIBRATE 123 95 28 56
DONEPEZIL HCL 123 120 28 29
ZOLPIDEM TARTRATE 118 106 30 25
BENAZEPRIL-HYDROCHLOROTHIAZIDE 109 103 31 133
BISOPROLOL-HYDROCHLOROTHIAZIDE 104 95 32 108
ALLOPURINOL 91 91 33 24
MIRTAZAPINE 88 88 34 50
LANTUS 82 77 35 38
NEXIUM 78 77 36 47
TRIAMTERENE-HCTZ 75 75 37 33
SPIRIVA 71 67 38 66
MELOXICAM 64 52 39 35
DIGOXIN 63 63 40 43
NIASPAN 63 58 40 132
PANTOPRAZOLE SODIUM 62 50 42 54
SERTRALINE HCL 62 54 42 22
ADVAIR DISKUS 59 48 44 55
ISOSORBIDE MONONITRATE ER 59 59 44 40
PREDNISONE 58 58 46 28
IPRATROPIUM BROMIDE 57 57 47 200
CLOPIDOGREL 57 56 47 48
NAMENDA 57 57 47 36
OXYBUTYNIN CHLORIDE ER 56 56 50 119
CLONIDINE HCL 55 41 51 88
TERAZOSIN HCL 55 55 51 81
FENTANYL 55 55 S2 51 51
HYDRALAZINE HCL 53 53 54 159
METFORMIN HCL ER 53 45 54 58
QUETIAPINE FUMARATE 51 48 56 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.